Dr. Burke on Treatment Options in Low-Tumor Burden Follicular Lymphoma

Video

John M. Burke, MD, discusses treatment options for patients with early-stage or advanced follicular lymphoma with a low tumor burden.

John M. Burke, MD, associate chair of the Hematology Research Program for US Oncology and medical oncologist and hematologist at Rocky Mountain Cancer Centers, discusses treatment options for patients with early-stage or advanced follicular lymphoma with a low tumor burden.

Patients with early-stage follicular lymphoma are often treated with localized radiation therapy, explains Burke. These patients tend to have stage 1 disease and may have 1 lymph node involved.

Conversely, patients with stage 3 or 4 advanced follicular lymphoma who are asymptomatic and have a low tumor burden are often considered for active surveillance, Burke says.

For patients who do not feel comfortable going without treatment, single-agent rituximab (Rituxan) could be considered, concludes Burke.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine